Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Immunocytochemical study of Ki-67 as a prognostic marker in canine mammary neoplasia.

Immunocytochemical study of Ki-67 as a prognostic marker in canine mammary neoplasia. Canine mammary tumors are challenging for clinicians and pathologists because of complex histologic classification, low specificity of cytologic diagnosis, and unpredictable biological behavior. In histologic specimens, expression of tumor proliferation marker Ki-67, a nuclear nonhistone protein, has been shown to have prognostic value for canine mammary tumors and to correlate with malignancy and low survival rates. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Veterinary clinical pathology Pubmed

Immunocytochemical study of Ki-67 as a prognostic marker in canine mammary neoplasia.

Veterinary clinical pathology , Volume 33 (1): 6 – Jul 26, 2004

Immunocytochemical study of Ki-67 as a prognostic marker in canine mammary neoplasia.


Abstract

Canine mammary tumors are challenging for clinicians and pathologists because of complex histologic classification, low specificity of cytologic diagnosis, and unpredictable biological behavior. In histologic specimens, expression of tumor proliferation marker Ki-67, a nuclear nonhistone protein, has been shown to have prognostic value for canine mammary tumors and to correlate with malignancy and low survival rates.

Loading next page...
 
/lp/pubmed/immunocytochemical-study-of-ki-67-as-a-prognostic-marker-in-canine-80UAKEP0Ls

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
0275-6382
pmid
15048623

Abstract

Canine mammary tumors are challenging for clinicians and pathologists because of complex histologic classification, low specificity of cytologic diagnosis, and unpredictable biological behavior. In histologic specimens, expression of tumor proliferation marker Ki-67, a nuclear nonhistone protein, has been shown to have prognostic value for canine mammary tumors and to correlate with malignancy and low survival rates.

Journal

Veterinary clinical pathologyPubmed

Published: Jul 26, 2004

There are no references for this article.